tyc7111cc太阳成集团

洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
医药数据查询

【ChiCTR2200061817】Clinical Training Dosage of Robotic Exoskeleton Assisted Gait Training for Improvement of Gait Parameters, Walking Performance, Balance and Health-related Benefits in Patients with Chronic Stroke: a Randomized Control Trial

基本信息
登记号

ChiCTR2200061817

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2022-07-03

临床申请受理号

/

靶点

/

适应症

Stroke

试验通俗题目

Clinical Training Dosage of Robotic Exoskeleton Assisted Gait Training for Improvement of Gait Parameters, Walking Performance, Balance and Health-related Benefits in Patients with Chronic Stroke: a Randomized Control Trial

试验专业题目

Clinical Training Dosage of Robotic Exoskeleton Assisted Gait Training for Improvement of Gait Parameters, Walking Performance, Balance and Health-related Benefits in Patients with Chronic Stroke: a Randomized Control Trial

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

To evaluate the most efficient clinical training dosage of powered robotic exoskeleton assisted gait training for improvement of gait parameters, walking performance, balance and health-related benefits in patients with chronic stroke.

试验分类
试验类型

整群随机分组

试验分期

其它

随机化

Randomisation sequence to be generated by online randomisation generator

盲法

/

试验项目经费来源

Institutional Development Grant

试验范围

/

目标入组人数

7

实际入组人数

/

第一例入组时间

2022-06-20

试验终止时间

2023-06-20

是否属于一致性

/

入选标准

Participants will be recruited if they fulfill the following inclusion criteria: 1. Currently in the chronic phase of stroke (>= 6 months post stroke); 2. Able to walk with supervision; 3. Body weight equals to or is less than 100 kg; 4. There are no severe deformities, spasticity or restricted motion in the legs; 5. Able to follow verbal instructions.；

排除标准

Not cooperative or have unstable medical conditions or musculoskeletal diseases which affect mobility.；

研究者信息
研究负责人姓名
试验机构

Caritas Institute of Higher Education

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址

最新临床资讯

tyc7111cc太阳成集团企业版
50亿+条医药数据随时查
7天免费试用
体验产品